Lista de obras - Jaime Calvo Alén - Dominio Público Uruguay

A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE.

artículo científico publicado en 2007

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain

scientific article published on 05 December 2019

Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry

artículo científico publicado en 2015

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

artículo científico publicado en 2008

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

artículo científico publicado en 2016

Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus C

artículo científico publicado en 2015

Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry

scientific article published on 01 January 2003

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study

artículo científico publicado en 2016

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences

artículo científico publicado en 2015

Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL).

artículo científico publicado en 2006

Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs

scientific article published on 16 April 2019

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

artículo científico publicado en 2007

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

artículo científico publicado en 2012

Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review ⬇️

artículo científico publicado el 1 de noviembre de 2013

Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy

artículo científico publicado en 2009

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus

artículo científico publicado en 2015

Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study

artículo científico publicado en 2017

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

artículo científico publicado en 2017

Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

artículo científico publicado en 2017

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

artículo científico publicado en 2020

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

artículo científico publicado en 2016

Opioids in chronic musculoskeletal conditions ⬇️

artículo científico publicado el 1 de octubre de 2010

Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions

artículo científico publicado en 2013

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients

artículo científico publicado en 2002

Primary Sjögren syndrome: hematologic patterns of disease expression

artículo científico publicado en 2002

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

artículo científico publicado en 2017

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

artículo científico publicado en 2016

Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.

artículo científico publicado en 2018

Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture?

artículo científico publicado en 2007

Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events

artículo científico publicado en 2005

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women

artículo científico publicado en 2007

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

artículo científico publicado en 2005

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study

artículo científico publicado en 2005

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

artículo científico publicado en 2005

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

artículo científico publicado en 2006

The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91-108. doi:10.1007/s12325-016-0441-3

artículo científico publicado en 2017

Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.

artículo científico publicado en 2014

Tocilizumab in refractory aortitis: study on 16 patients and literature review

artículo científico publicado en 2014

Utilizing registries in systemic lupus erythematosus clinical research ⬇️

artículo científico publicado el 1 de mayo de 2012

Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico ⬇️

artículo científico publicado el 17 de julio de 2013

Lista de obras de Jaime Calvo Alén

A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE.

Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain

Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus C

Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences

Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL).

Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review ⬇️

Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus

Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.

Opioids in chronic musculoskeletal conditions ⬇️

Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients

Primary Sjögren syndrome: hematologic patterns of disease expression

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.

Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture?

Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time

The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91-108. doi:10.1007/s12325-016-0441-3

Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.

Tocilizumab in refractory aortitis: study on 16 patients and literature review

Utilizing registries in systemic lupus erythematosus clinical research ⬇️

Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico ⬇️